Works matching IS 1747-0277 AND VI 100 AND IP 2 AND DT 2022

Results: 11

Exploring novel nitrofuranyl sulfonohydrazides as anti‐Leishmania and anti‐cancer agents: Synthesis, in vitro efficacy and hit identification.

Published in:

Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. 267, doi. 10.1111/cbdd.14097

By:

Kannigadu, Christina;
Aucamp, Janine;
N'Da, David D.

Publication type:

Article

2, 4, 5‐Trideoxyhexopyranosides derivatives of diphyllin: Synthesis and anticancer activity.

Published in:

Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. 256, doi. 10.1111/cbdd.14095

By:

Cai, Rui;
Li, Yu;
Zhu, Li;
Wei, Caiyan;
Bao, Xiaofeng;
Zhao, Yu

Publication type:

Article

Synthesis, molecular docking, and biological evaluation of novel 1,2,4‐triazole‐isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.

Published in:

Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. 230, doi. 10.1111/cbdd.14060

By:

Dadlani, Vedika G.;
Chhabhaiya, Heta;
Somani, Rakesh R.;
Tripathi, Pushpendra K.

Publication type:

Article

Predicting clinical trial outcomes using drug bioactivities through graph database integration and machine learning.

Published in:

Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. 169, doi. 10.1111/cbdd.14092

By:

Murali, Vidhya;
Muralidhar, Y. Pradyumna;
Königs, Cassandra;
Nair, Meera;
Madhu, Sethulekshmi;
Nedungadi, Prema;
Srinivasa, Gowri;
Athri, Prashanth

Publication type:

Article

Hydroxybenzamide derivatives protect pancreatic β cell by suppressing unfolded protein response activation.

Published in:

Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. 155, doi. 10.1111/cbdd.14093

By:

Eeda, Venkateswararao;
Rawal, Komal N.;
Matlock, H. Greg;
Herlea‐Pana, Oana;
Lim, Hui‐Ying;
Wang, Weidong

Publication type:

Article

Application of kojic acid scaffold in the design of non‐tyrosinase enzyme inhibitors.

Published in:

Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. 290, doi. 10.1111/cbdd.14065

By:

Ashooriha, Morteza;
Ahmadi, Reza;
Ahadi, Hamideh;
Emami, Saeed

Publication type:

Article

MiR‐27a‐3p targets USP46 to inhibit the cell proliferation of hepatocellular carcinoma.

Published in:

Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. 280, doi. 10.1111/cbdd.14063

By:

Wen, Minghua;
Xu, Hongyan;
Peng, Hong;
Sheng, Yanling;
Yang, Wenlong;
Yan, Jinlong

Publication type:

Article

Synergy between machine learning and natural products cheminformatics: Application to the lead discovery of anthraquinone derivatives.

Published in:

2022

By:

Moshawih, Said;
Goh, Hui Poh;
Kifli, Nurolaini;
Idris, Azam Che;
Yassin, Hayati;
Kotra, Vijay;
Goh, Khang Wen;
Liew, Kai Bin;
Ming, Long Chiau

Publication type:

Literature Review

Methyl benzoate and cinnamate analogs as modulators of DNA methylation in hepatocellular carcinoma.

Published in:

Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. 245, doi. 10.1111/cbdd.14061

By:

Castro‐Vazquez, Diana;
Sánchez‐Carranza, Jessica Nayelli;
Alvarez, Laura;
Juárez‐Mercado, Karina Eurídice;
Sánchez‐Cruz, Noberto;
Medina‐Franco, José L.;
Antunez‐Mojica, Mayra;
González‐Maya, Leticia

Publication type:

Article

Punicalagin suppresses inflammation in ventilator‐induced lung injury through protease‐activated receptor‐2 inhibition‐induced inhibition of NLR family pyrin domain containing‐3 inflammasome activation.

Published in:

Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. 218, doi. 10.1111/cbdd.14059

By:

Zhang, Wei;
Zhu, Qi

Publication type:

Article

Cover Image.

Published in:: Chemical Biology & Drug Design, 2022, v. 100, n. 2, p. i, doi. 10.1111/cbdd.13883
Publication type:: Article